Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Positive Side of the Alzheimer’s Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1
Lidia Ciccone, Chenghui Shi, Davide Di Lorenzo, et al.
Molecules (2020) Vol. 25, Iss. 10, pp. 2439-2439
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer’s disease
Joan Jiménez-Baladó, Teal S. Eich
Seminars in Cell and Developmental Biology (2021) Vol. 116, pp. 146-159
Open Access | Times Cited: 130
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 129
Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target Tauopathies
Galina Limorenko, Hilal A. Lashuel
Chemical Society Reviews (2021) Vol. 51, Iss. 2, pp. 513-565
Open Access | Times Cited: 113
Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy
Yingxu Fang, Jiaxing Wang, Min Zhao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 17, pp. 11454-11477
Closed Access | Times Cited: 49
Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer's disease
Haleh Barmaki, Alireza Nourazarian, Fatemeh Khaki‐Khatibi
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 22
Nanotechnology-Driven Therapeutic Innovations in Neurodegenerative Disorders: A Focus on Alzheimer’s and Parkinson’s Disease
Antea Kršek, Lara Batičić
Future Pharmacology (2024) Vol. 4, Iss. 2, pp. 352-379
Open Access | Times Cited: 9
The Effects of Aβ1-42 Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2
John Hsu, Chih-Feng Tien, Guann‐Yi Yu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8226-8226
Open Access | Times Cited: 47
Potential neuroprotection by Dendrobium nobile Lindl alkaloid in Alzheimer’s disease models
Feng Zhang, Shi Jing-shan, Daidi Li, et al.
Neural Regeneration Research (2021) Vol. 17, Iss. 5, pp. 972-972
Open Access | Times Cited: 42
HDL Proteome and Alzheimer’s Disease: Evidence of a Link
Judit Marsillach, Maria Pia Adorni, Francesca Zimetti, et al.
Antioxidants (2020) Vol. 9, Iss. 12, pp. 1224-1224
Open Access | Times Cited: 45
Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer’s Disease
Lidia Ciccone, Jennifer Vandooren, Susanna Nencetti, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 86-86
Open Access | Times Cited: 33
Stress-responsive regulation of extracellular proteostasis
Jaleh S. Mesgarzadeh, Joel N. Buxbaum, R. Luke Wiseman
The Journal of Cell Biology (2022) Vol. 221, Iss. 4
Open Access | Times Cited: 25
Exploitation of Marine Molecules to Manage Alzheimer’s Disease
Marisa Silva, Paula Seijas, Paz Otero
Marine Drugs (2021) Vol. 19, Iss. 7, pp. 373-373
Open Access | Times Cited: 28
Aβ and Tau Interact with Metal Ions, Lipid Membranes and Peptide-Based Amyloid Inhibitors: Are These Common Features Relevant in Alzheimer’s Disease?
Giuseppe Di Natale, Giuseppina Sabatino, Michele F. M. Sciacca, et al.
Molecules (2022) Vol. 27, Iss. 16, pp. 5066-5066
Open Access | Times Cited: 22
Microglial cathepsin E plays a role in neuroinflammation and amyloid β production in Alzheimer’s disease
Zhen Xie, Jie Meng, Wei Kong, et al.
Aging Cell (2022) Vol. 21, Iss. 3
Open Access | Times Cited: 20
The evolving role of cholesteryl ester transfer protein inhibition beyond cardiovascular disease
Nehal N. Mehta, Katerina Dangas, Marc Ditmarsch, et al.
Pharmacological Research (2023) Vol. 197, pp. 106972-106972
Open Access | Times Cited: 11
The role of machine learning in discovering biomarkers and predicting treatment strategies for neurodegenerative diseases: A narrative review
Abdullahi Tunde Aborode, Ogunware Adedayo Emmanuel, Isreal Ayobami Onifade, et al.
NeuroMarkers. (2025) Vol. 2, Iss. 1, pp. 100034-100034
Open Access
Mechanism of interaction between TTR tetramer and Aβ42 oligomers: Dependence on the Aβ42 oligomeric size and morphology
Jinfei Mei, Wenqi Gao, Yvning Guan, et al.
ChemPhysMater (2025)
Open Access
Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer's disease: Where are our knowledge
Shahram Darabi, Enam Alhagh Charkhat Gorgich, Fatemeh Moradi, et al.
IBRO Neuroscience Reports (2025) Vol. 18, pp. 191-199
Closed Access
Developing Non-Invasive Molecular Markers for Early Risk Assessment of Alzheimer's Disease
Tapas Kumar Sur, Tanmoy Mondal, Zarish Noreen, et al.
Biomarkers in Neuropsychiatry (2025), pp. 100120-100120
Open Access
Molecular Simulation of the Binding of Amyloid Beta to Apolipoprotein A-I in High-Density Lipoproteins
Chris J. Malajczuk, Ricardo L. Mancera
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1380-1380
Open Access
HDL‐Apolipoprotein in Alzheimer's Disease Revisited: From Periphery to CNS
Yihong Huang, Jingyi Tang, Guohua Chen, et al.
Aging Medicine (2025)
Open Access
Extracellular PHF-tau modulates astrocyte mitochondrial dynamics and mediates neuronal connectivity
Valentin Zufferey, Aatmika Barve, Enea Parietti, et al.
Translational Neurodegeneration (2025) Vol. 14, Iss. 1
Open Access
Transthyretin as a therapeutic target: the future of disease-modifying therapies for Alzheimer’s disease
Swetaleena Shaw, Pratyush Porel, Khadga Raj Aran
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Harnessing Marine Resources for Alzheimer’s Therapy: A Review Integrating Bioactivity and Molecular Docking
Hinnan Khalid, Hassan Mohamed, Adel Elthoukhy, et al.
European Journal of Pharmacology (2025), pp. 177611-177611
Closed Access
BODIPY Dyes as Probes and Sensors to Study Amyloid-β-Related Processes
Sergei V. Dzyuba
Biosensors (2020) Vol. 10, Iss. 12, pp. 192-192
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top